Overview Dividends

(IFF) International Flavors - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4595061015

Flavors, Fragrances, Excipients, Cultures, Enzymes

IFF EPS (Earnings per Share)

EPS Growth (3Y CAGR): 2.92%
EPS Trend (3Y Correlation): 35.6%

IFF Revenue

Revenue Growth (3Y CAGR): -1.95%
Revenue Trend (3Y Correlation): -53.7%

Risk via 10d forecast
Volatility	26.5%
Value at Risk 5%th	39.6%
Relative Tail Risk	-9.09%

Reward TTM
Sharpe Ratio	-0.98
Alpha	-35.41

Character TTM
Hurst Exponent	0.585
Beta	0.719
Beta Downside	0.498

Drawdowns 3y
Max DD	45.07%
Mean DD	24.79%
Median DD	27.11%

Description: IFF International Flavors October 30, 2025

International Flavors & Fragrances Inc. (NYSE:IFF) manufactures and markets a broad portfolio of ingredients and solutions across food, beverage, health, biosciences, fragrance, and pharmaceutical excipients, serving customers in the United States, Europe, and globally.

The company operates in four reporting segments: Nourish (natural-based food ingredients such as plant-protein, sweeteners, and flavor compounds), Health & Biosciences (cultures, enzymes, animal nutrition, and grain-processing solutions), Scent (fragrance compounds and ingredients), and Pharma Solutions (cellulosic and seaweed-based excipients).

Key financial metrics from FY 2023 show IFF generated roughly $10.5 billion in revenue with an adjusted operating margin of about 14 %, while R&D spending remained near $800 million, underscoring its emphasis on innovation in high-growth categories.

Sector drivers include the rapid expansion of the plant-based protein market (CAGR ~9 % through 2028), continued premiumization in the global fragrance industry (valued at >$30 billion), and rising demand for natural preservative solutions driven by clean-label trends.

For a deeper, data-driven valuation framework, you may find ValueRay’s sector-specific models useful.

IFF Stock Overview

Market Cap in USD	15,878m
Sub-Industry	Specialty Chemicals
IPO / Inception	1981-12-31
Return 12m vs S&P 500	-32.7%
Analyst Rating	4.14 of 5

IFF Dividends

Dividend Yield	2.37%
Yield on Cost 5y	1.60%
Yield CAGR 5y	-14.83%
Payout Consistency	97.4%
Payout Ratio	36.6%

IFF Growth Ratios

CAGR 3y	-9.25%
CAGR/Max DD Calmar Ratio	-0.21
CAGR/Mean DD Pain Ratio	-0.37
Current Volume	3638.9k
Average Volume	2243.9k

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income (-412.0m TTM) > 0 and > 6% of Revenue (6% = 664.3m TTM)

FCFTA 0.01 (>2.0%) and ΔFCFTA -1.80pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 16.32% (prev 45.59%; Δ -29.27pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.03 (>3.0%) and CFO 900.0m > Net Income -412.0m (YES >=105%, WARN >=100%)

Net Debt (6.52b) to EBITDA (698.0m) ratio: 9.35 <= 3.0 (WARN <= 3.5)

Current Ratio 1.44 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (257.0m) change vs 12m ago 0.0% (target <= -2.0% for YES)

Gross Margin 36.38% (prev 35.07%; Δ 1.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 39.76% (prev 38.14%; Δ 1.61pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -1.08 (EBITDA TTM 698.0m / Interest Expense TTM 249.0m) >= 6 (WARN >= 3)

Altman Z'' -0.46

(A) 0.07 = (Total Current Assets 5.88b - Total Current Liabilities 4.07b) / Total Assets 25.77b

(B) -0.13 = Retained Earnings (Balance) -3.35b / Total Assets 25.77b

(D) -0.42 = Book Value of Equity -4.77b / Total Liabilities 11.49b

Total Rating: -0.46 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 38.28

1. Piotroski 4.50pt = -0.50

2. FCF Yield 1.49% = 0.75

3. FCF Margin 3.00% = 0.75

4. Debt/Equity 0.50 = 2.38

5. Debt/Ebitda 9.35 = -2.50

6. ROIC - WACC (= -7.88)% = -9.85

7. RoE -2.96% = -0.49

8. Rev. Trend -53.70% = -4.03

9. EPS Trend 35.56% = 1.78

What is the price of IFF shares?

As of November 15, 2025, the stock is trading at USD 67.43 with a total of 3,638,860 shares traded.
Over the past week, the price has changed by +7.29%, over one month by +12.20%, over three months by +2.06% and over the past year by -23.30%.

Is International Flavors a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, International Flavors (NYSE:IFF) is currently (November 2025) a stock to sell. It has a ValueRay Fundamental Rating of 38.28 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IFF is around 56.43 USD . This means that IFF is currently overvalued and has a potential downside of -16.31%.

Is IFF a buy, sell or hold?

International Flavors has received a consensus analysts rating of 4.14. Therefore, it is recommended to buy IFF.

Strong Buy: 10
Buy: 7
Hold: 4
Sell: 0
Strong Sell: 1

What are the forecasts/targets for the IFF price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	81.8	21.4%
Analysts Target Price	81.8	21.4%
ValueRay Target Price	62.1	-7.9%

IFF Fundamental Data Overview November 11, 2025

Market Cap USD = 15.88b (15.88b USD * 1.0 USD.USD)
P/E Forward = 14.0845
P/S = 1.4341
P/B = 1.0944
P/EG = 0.7371
Beta = 1.053
Revenue TTM = 11.07b USD
EBIT TTM = -270.0m USD
EBITDA TTM = 698.0m USD
Long Term Debt = 7.56b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.31b USD (from shortTermDebt, last quarter)
Debt = 7.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.52b USD (from netDebt column, last quarter)
Enterprise Value = 22.25b USD (15.88b + Debt 7.14b - CCE 773.0m)
Interest Coverage Ratio = -1.08 (Ebit TTM -270.0m / Interest Expense TTM 249.0m)
FCF Yield = 1.49% (FCF TTM 332.0m / Enterprise Value 22.25b)
FCF Margin = 3.00% (FCF TTM 332.0m / Revenue TTM 11.07b)
Net Margin = -3.72% (Net Income TTM -412.0m / Revenue TTM 11.07b)
Gross Margin = 36.38% ((Revenue TTM 11.07b - Cost of Revenue TTM 7.04b) / Revenue TTM)
Gross Margin QoQ = 36.49% (prev 37.26%)
Tobins Q-Ratio = 0.86 (Enterprise Value 22.25b / Total Assets 25.77b)
Interest Expense / Debt = 0.67% (Interest Expense 48.0m / Debt 7.14b)
Taxrate = 26.79% (15.0m / 56.0m)
NOPAT = -197.7m (EBIT -270.0m * (1 - 26.79%)) [loss with tax shield]
Current Ratio = 1.44 (Total Current Assets 5.88b / Total Current Liabilities 4.07b)
Debt / Equity = 0.50 (Debt 7.14b / totalStockholderEquity, last quarter 14.24b)
Debt / EBITDA = 9.35 (Net Debt 6.52b / EBITDA 698.0m)
Debt / FCF = 19.65 (Net Debt 6.52b / FCF TTM 332.0m)
Total Stockholder Equity = 13.92b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.60% (Net Income -412.0m / Total Assets 25.77b)
RoE = -2.96% (Net Income TTM -412.0m / Total Stockholder Equity 13.92b)
RoCE = -1.26% (EBIT -270.0m / Capital Employed (Equity 13.92b + L.T.Debt 7.56b))
RoIC = -0.90% (negative operating profit) (NOPAT -197.7m / Invested Capital 21.97b)
WACC = 6.98% (E(15.88b)/V(23.02b) * Re(9.90%) + D(7.14b)/V(23.02b) * Rd(0.67%) * (1-Tc(0.27)))
Discount Rate = 9.90% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.39%
[DCF Debug] Terminal Value 62.56% ; FCFE base≈569.2m ; Y1≈373.7m ; Y5≈170.9m
Fair Price DCF = 9.93 (DCF Value 2.54b / Shares Outstanding 256.1m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 35.56 | EPS CAGR: 2.92% | SUE: 0.09 | # QB: 0
Revenue Correlation: -53.70 | Revenue CAGR: -1.95% | SUE: 1.54 | # QB: 2

Additional Sources for IFF Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle